Cell-Penetrating Peptide Delivery for CRISPR Applications
Authors:
Open Access
- 23 September 2026
- book chapter
- Published by Springer Nature
- Vol. 3075, 275-297
Abstract
Cell-penetrating peptides (CPPs) provide a modular nonviral strategy for intracellular delivery of CRISPR/Cas9 components, particularly preassembled Cas9 ribonucleoprotein (RNP) complexes. This chapter summarizes key principles of CPP-mediated Cas9 RNP delivery, including noncovalent complexation and covalent CPP–Cas9 conjugation strategies. A representative protocol is provided for the preparation and evaluation of Cas9-K5 RNP, including in vitro uptake and reporter-editing assays, nucleofection-based functional controls, local intracranial delivery, immunofluorescence staining, and quantitative analysis of reporter activation in brain tissue.Keywords
This publication has 40 references indexed in Scilit:
- Cell Penetrating Peptides: Classification, Mechanisms, Methods of Study, and ApplicationsChemMedChem, 2023
- The Coiled‐Coil Forming Peptide (KVSALKE)5 Is a Cell Penetrating Peptide that Enhances the Intracellular Delivery of ProteinsAdvanced Healthcare Materials, 2021
- Challenges in delivery systems for CRISPR-based genome editing and opportunities of nanomedicineBiomedical Engineering Letters, 2021
- Cell-Penetrating Peptide-Mediated Delivery of Cas9 Protein and Guide RNA for Genome Editing2016
- On the importance of electrostatic interactions between cell penetrating peptides and membranes: A pathway toward tumor cell selectivity?Biochimie, 2014
- Different membrane behaviour and cellular uptake of three basic arginine-rich peptidesBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Cell penetrating peptides: overview and applications to the delivery of oligonucleotidesCellular and Molecular Life Sciences, 2009
- HIV TAT Forms Pores in Membranes by Inducing Saddle‐Splay Curvature: Potential Role of Bidentate Hydrogen BondingAngewandte Chemie International Edition, 2008
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988
- Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator proteinCell, 1988